MHRA: Stop supplying certain batches of Sanofi Stemetil Syrup ‘immediately’

The Medicines and Healthcare products Regulatory Agency (MHRA) has asked pharmacies to stop the supply of specific batches of Sanofi's Stemetil Syrup “immediately”, after levels “above the acceptable limit” of N-nitrosomethylphenylamine were identified.